Condition
Thalassemia Majors (Beta-Thalassemia Major)
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07288762Not Yet RecruitingPrimary
Gonadal Function in Thalassemic Patient
NCT06980662Not ApplicableNot Yet Recruiting
The Effect of Laughter Yoga in Beta Thalassaemia Major Patients: a Randomised Controlled Trial
NCT06734520Not ApplicableRecruitingPrimary
Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia
NCT03040765Phase 3TerminatedPrimary
Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis
Showing all 4 trials